Be Prepared to Treat Multidrug-Resistant "ESBL" and "CRE" Infections
April 2017
You'll hear more about treating "superbugs" such as ESBL and CRE...due to a push from the World Health Organization.
Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are popping up everywhere. And most states are reporting carbapenem-resistant Enterobacteriaceae (CRE)...which is fatal in about 50% of cases.
Help prevent progression of superbugs with judicious antibiotic use.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote